The market cap of $120m is really strange. It should rightly be down in the the ~$20m range.
Basically a couple of pre-clinical assets, with a bit of safety work done with no independent evidence of efficacy apart from "Recce says it works", and a history of moving goalposts and burying results.
I think it's only partly explained by the large family holdings and very good marketing to retail investors.
A real head scratcher...
RCE Price at posting:
69.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)